Market Tracker

04/17 2:38pm ET

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

0.9788
Data as of 2:20pm ET
 -0.0091 / -0.92%
Today’s Change
0.78
Today|||52-Week Range
2.89
-15.62%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close0.99
Today’s open0.99
Day’s range0.92 - 1.00
Volume135,511
Average volume (3 months)560,295
Market cap$35.7M
Dividend yield--
Data as of 2:20pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-241.48%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-19.03%
P/E ratio7.0
Price/Sales1.47
Price/Book6.80

Competitors

 Today’s
change
Today’s
% change
CBLICleveland Biolabs In...-0.03-4.79%
ECTEEcho Therapeutics In...-0.03-0.96%
HTBXHeat Biologics Inc+0.24+4.49%
CTRVContraVir Pharmaceut...+0.02+1.01%
Data as of 2:22pm ET, 04/17/2014

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$34.5M
Annual profit (last year)$18.2M
Net profit margin52.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
George W. Hebard
Chief Financial Officer &
Vice President-Finance
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts